Dynavax Technologies Corp. (DVAX)
Dynavax Technologies Market Cap: 1.806B for Dec. 26, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Merck & Co., Inc. | 265.03B |
| Agios Pharmaceuticals, Inc. | 1.634B |
| Hyperion DeFi, Inc. | 31.10M |
| Edgewise Therapeutics, Inc. | 2.790B |
| Moderna, Inc. | 12.19B |
Market Cap Related Metrics
| PS Ratio | 6.43 |
| Price to Book Value | 3.381 |
| Price to Free Cash Flow | 26.39 |
| Price | 15.38 |
| Earnings Yield | -2.48% |
| Operating PE Ratio | 203.60 |
| Normalized PE Ratio | 196.42 |